Skip to main content

Table 3 MSA type, titer, and CK level in patients with positive MSA (n = 26)

From: Distinct tissue injury patterns in juvenile dermatomyositis auto-antibody subgroups

  AGE SEX MSA TYPE Mi-2
titer
NXP-2
titer
MDA-5
titer
TIF1γ
titer
SRP
titer
CK
1 10 M MDA5    50    126
2 5 M MDA5    50    103
3 12 F MDA5    13    88
4 12 F MI2 ≥100      14,152
5 4 F MI2 97      18,992
6 16 F MI2 91      14,119
7 4 F MI2 47      3077
8 5 F MI2 32      1491
9 2 F NXP2   ≥100     475
10 3 M NXP2   ≥100     74
11 12 F NXP2   ≥100     1044
12 13 F NXP2   ≥100     147
13 8 F NXP2   52     1438
14 3 F NXP2   30     229
15 4 M NXP2   16     1040
16 8 F NXP2   12     4681
17 10 F NXP2   11     47
18 12 F TIF1γ     84   402
19 12 F PL7       13,972
20 8 F SRP      24 132
21 4 M SRP, TIF1γ     13 58 93
22 4 F NXP2, MDA5   ≥100 34    3860
23 5 F NXP2, MI2 98 ≥100     633
24 3 F NXP2, OJ   ≥100     1242
25 3 M NXP2, SRP   ≥100    12 190
26 3 F MI2, MDA5 16   11    117